TREM2 and Alzheimer disease: TREM2 R47H AD patients demonstrated a shortened course of the disease, pronounced synucleinopathy, changed microglial morphology, and decreased level of the microglial marker Iba1, suggesting that compromised TREM2 signaling has a strong effect on microglia function in the disease.